Shaw Philip, Sharp Wendy S, Morrison Meaghan, Eckstrand Kristen, Greenstein Deanna K, Clasen Liv S, Evans Alan C, Rapoport Judith L
Child Psychiatry Branch, Bldg. 10, Center Dr., NIMH, Bethesda, MD 20892, USA.
Am J Psychiatry. 2009 Jan;166(1):58-63. doi: 10.1176/appi.ajp.2008.08050781. Epub 2008 Sep 15.
While there has been considerable concern over possible adverse effects of psychostimulants on brain development, this issue has not been examined in a prospective study. The authors sought to determine prospectively whether psychostimulant treatment for attention deficit hyperactivity disorder (ADHD) was associated with differences in the development of the cerebral cortex during adolescence.
Change in cortical thickness was estimated from two neuroanatomic MRI scans in 43 youths with ADHD. The mean age at the first scan was 12.5 years, and at the second scan, 16.4 years. Nineteen patients not treated with psychostimulants between the scans were compared with an age-matched group of 24 patients who were treated with psychostimulants. Further comparison was made against a template derived from 620 scans of 294 typically developing youths without ADHD.
Adolescents taking psychostimulants differed from those not taking psychostimulants in the rate of change of the cortical thickness in the right motor strip, the left middle/inferior frontal gyrus, and the right parieto-occipital region. The group difference was due to more rapid cortical thinning in the group not taking psychostimulants (mean cortical thinning of 0.16 mm/year [SD=0.17], compared with 0.03 mm/year [SD=0.11] in the group taking psychostimulants). Comparison against the typically developing cohort without ADHD showed that cortical thinning in the group not taking psychostimulants was in excess of age-appropriate rates. The treatment groups did not differ in clinical outcome, however.
These findings show no evidence that psychostimulants were associated with slowing of overall growth of the cortical mantle.
尽管人们一直相当关注精神兴奋剂对大脑发育可能产生的不良影响,但这一问题尚未在前瞻性研究中得到检验。作者试图前瞻性地确定,用于治疗注意力缺陷多动障碍(ADHD)的精神兴奋剂治疗是否与青少年期大脑皮质发育的差异有关。
对43名患有ADHD的青少年进行两次神经解剖学MRI扫描,以估计皮质厚度的变化。第一次扫描时的平均年龄为12.5岁,第二次扫描时为16.4岁。将扫描期间未接受精神兴奋剂治疗的19名患者与年龄匹配的24名接受精神兴奋剂治疗的患者进行比较。进一步与从294名无ADHD的正常发育青少年的620次扫描中得出的模板进行比较。
服用精神兴奋剂的青少年与未服用精神兴奋剂的青少年在右侧运动区、左侧额中/下回和右侧顶枕区的皮质厚度变化率上存在差异。组间差异是由于未服用精神兴奋剂的组皮质变薄更快(平均皮质变薄0.16毫米/年[标准差=0.17],而服用精神兴奋剂的组为0.03毫米/年[标准差=0.11])。与无ADHD的正常发育队列相比,未服用精神兴奋剂的组皮质变薄超过了适合其年龄的速率。然而,治疗组在临床结果上没有差异。
这些发现没有证据表明精神兴奋剂与皮质层整体生长放缓有关。